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Background: HIV, HBV, Syphilis and HCV share common modes of transmission.
Objective: The study was aimed to determine the co-infection rate of HIV, HBV and Syphilis among HCV
seropositive identified blood donors.
Methods: The study was conducted on blood samples screened as HCV seropositive at Nepal Red Cross
Society, Central Blood Transfusion Service, Kathmandu, Nepal. HCV seropositive samples were further
tested for HIV, HBV and Syphilis.
Results: Eight co-infections were observed in 139 HCV seropositives with total co-infection rate of 5.75%
(95% CI2.5211.03).
Conclusion: Co-infection of HIV, HBV and Syphilis with HCV is prevalent in the healthy looking blood
donors of Kathmandu, Nepal.
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C
ommon mode of transmission of various infec-
tions can result in the simultaneous prevalence of
these infections in the same human population.
Worldwide, hepatitis B virus (HBV) accounts for an
estimated 370 million chronic infections, hepatitis C virus
(HCV) for an estimated 130 million, and HIV for an
estimated 40 million. In HIV-infected persons, an esti-
mated 24 million have chronic HBV co-infection and
45 million have HCV co-infection. HBV, HCV and HIV
share common routes of transmission, but they differ in
their prevalence by geographic region and the efficiency
by which certain types of exposures transmit them (1).
Syphilis being a sexually transmitted disease, its presence
points towards indulgence in ‘‘high risk’’ behaviour and
consequently higher risk of exposure to infections like
HIV and hepatitis (2).
In the year 2008, seroprevalence of HIV, HBV, HCV
and syphilis has been determined to be 0.12, 0.46, 0.64 and
0.48% respectively in the study conducted in Kathmandu,
Nepal (3). The study indicates prevalence of these infec-
tions which has common mode of transmission. However,
co-infection rate is yet to be estimated in the population
with such infection. Co-infection of HCV in HIV, HCV in
HBsAg, HBV in HIV has been estimated to be 10.8, 1.67
and 2.6% respectively in the Nepalese blood donors (46).
Co-incidence of HBV markers have been reported with
syphilis in Austria (7). The current investigation in
contrary gives the co-infection rate of HIV, HBV and
Syphilis in HCV seropositive blood donors.
The study was conducted to study the co-infection rate
of HIV, Hepatitis B and Syphilis among the Hepatitis C
seropositive cases (blood donors) visiting the Central
Blood Transfusion Service in Kathmandu where a mixed
population from all over the country resides. Determina-
tion of co-infection of these infections among healthy
looking blood donors yet seropositive to HCV, can
provide useful information on the behaviour pattern of
the general population such as HIV/HCV co-infection
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prevalence indicate HIV transmission among injecting
drug users who are usually infected with HCV. It is
estimated that 5090% of IDUs with HIV also have HCV
infection (8).
Materials and methods
The study was conducted from March 2008 till Septem-
ber 2008 among 139 HCV seropositive cases (identified
during the period) of 1860 years of age with both sexes
included. The cases were identified at Nepal Red Cross
Society (NRCS), Central Blood Transfusion Service
(CBTS), Kathmandu, Nepal. Information of the subjects
such as age and gender was accessed from the standard
blood donor questionnaire form of CBTS recorded by
health professionals from the blood donors. Samples were
tested with confidentiality and identified by the sample
code number given during the sample collection. Ethical
approval to conduct the study was taken from CBTS.
WHO strategy 2 for surveillance diagnosis of HIV was
used for the test of the samples (9). Samples were tested
with the kits recommended in use by CBTS. Blood
samples were tested for HCV using ELISA test kits
EIAgen HCV Ab kit (Adaltis, Italy) confirmed with SD
Bioline HCV (Standard Diagnostics, Inc., Korea).
HCV seropositive cases were tested for HIV, HBV and
Syphilis with ELISA test kits Enzygnost
†
Anti-HIV ½
Plus (Dade Behring, Germany), Enzygnost
†
HBsAg 5.0
(Dade Behring, Germany), SD Syphilis ELISA 3.0
(Standard Diagnostics, Inc., Korea) respectively. The
positive test results for HIV, HBV and Syphilis were
confirmed with rapid immunochromatographic test kits
SD Bioline HIV-½ 3.0 (Standard Diagnostics, Inc.,
Korea) and VirucheckHBsAg (Orchid Biomedical Sys-
tems, India) respectively while Syphilis was confirmed
with the same ELISA test kit. Test results with seropo-
sitivity for HIV, HBV and Syphilis among HCV positive
samples were considered to determine the co-infection
rate. Co-infection rate was determined in percentage and
95% confidence interval calculated.
Results
Among the 139 HCV seropositive cases, eight of them
were determined to have co-infections with total co-
infection rate of 5.75% (95% CI2.5211.03). Co-
infection rate of HIV among HCV was 3.59%, HBV
among HCV was 0.71% and Syphilis among HCV was
1.43% (Table 1). None of the HCV seropositive samples
were positive to more than one infection. All the
co-infection cases were male though 11 HCV seropositive
females were included in the study. HIV/HCV co-infec-
tion was seen in the age group between 2150 years.
HBV/HCV co-infection in the age group 3140 years and
Syphilis/HCV in the age group 2130 years.
Discussion
Prevalence of HIV, HBV and Syphilis co-infection among
HCV cases indicates that the infections could be trans-
mitted simultaneously due to their common modes of
transmission. HCV is more commonly transmitted
among IDUs and the co-infection of HIV, HBV and
Syphilis with HCV can be due to transmission modes
such as sharing of needles or unsafe sexual transmission
among such risk groups. HIV/HCV was the most
common co-infection followed by Syphilis/HCV and
HBV/HCV. Prevalence of higher HIV/HCV co-infection
in this study can be due to the practice of injecting drug
use as many IDUs who become infected with HIV are
already infected with HCV. HIV/HCV co-infection de-
termined is lower than the reported co-infection rate of
10.8% with HCV and HIV (4). Co-infection rate of HIV
in HCV estimated is similar to the reported rate of HCV
co-infection in HIV patients in North India (2.43%) and
2.2% reported in South India (10, 11). HBV/HCV co-
infection is lower than the HCV/HBV co-infection rate of
1.67% reported in Nepalese blood donors (5). Lower co-
infections rate in this study is due to the low-risk group of
population (healthy looking blood donors) considered;
decreasing prevalence of transfusion transmissible infec-
tions (3). Higher HIV/HCV co-infection indicates HIV
risks associated with the injecting drugs users who are
usually infected with HCV. Prevalence of co-infections
observed in the study in only males indicates indulgence
of such gender groups in unsafe practices that could have
transmitted the multiple infections. Monitoring of co-
infections is necessary to commence immediate treatment
of the cases besides prevention of transfusion associated
risks with such blood donors.
Co-infection of HIV, HBV and Syphilis with HCV is
prevalent in the blood donors of Kathmandu, Nepal.
Further investigations can be carried out with larger
sample size and in high risk groups with other infections
sharing common modes of transmission to estimate the
co-infections in the general population of the country.
Table 1. Co-infections in HCV seropositive blood donors
HCV seropositive Co-infection Number of co-infections Co-infection rate
139 HIV/HCV 5 3.59% (5/139) 95% CI1.188.19
HBV/HCV 1 0.71% (1/139) 95% CI0.023.94
Syphilis/HCV 2 1.43% (2/139) 95% CI0.015.1
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